• Genistein in Experimental Oncology: Assay Design and Cytoske

  2026-05-05

  Explore how Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one) enables precise inhibition of tyrosine kinases in cancer research. This article uniquely bridges cytoskeleton-dependent autophagy mechanisms with practical assay design, offering advanced guidance for experimental oncology.

• Drug-Sensitized Yeast Platform for High-Sensitivity mTOR Inh

  2026-05-04

  This study introduces a genetically engineered yeast system with enhanced drug sensitivity for the identification of mTOR inhibitors, achieving a remarkable increase in assay sensitivity compared to wild-type strains. The platform enables rapid, cost-effective screening of TOR pathway inhibitors, with precise differentiation between true inhibitors and compounds lacking TOR-targeted activity.

• Lactobacillus gasseri Modulates Colitis via NR1I3 and E-cadh

  2026-05-04

  Qian et al. (2024) demonstrate that Lactobacillus gasseri ATCC33323 ameliorates DSS-induced colitis in mice by regulating the intestinal mucosal barrier through NR1I3-mediated E-cadherin expression. This mechanistic insight advances understanding of probiotic-based interventions for inflammatory bowel disease and highlights the critical role of epithelial integrity.

• K+ Channel Blockade Impacts Renal Blood Flow in Septic Rats

  2026-05-03

  This study systematically examines how blocking distinct potassium channel subtypes alters renal blood flow responses to vasoactive agents in septic rats. The work reveals that abnormal K+ channel function in sepsis complicates therapeutic strategies targeting vascular tone, with implications for both experimental design and translational research in vascular biology.

• ERK Inhibition Mitigates Autophagy via Mitochondrial Dynamic

  2026-05-02

  Yuan et al. (2023) elucidate how ERK inhibition protects neuronal cells from ischemia-reperfusion injury by modulating mitochondrial fragmentation and downregulating autophagy. Their findings clarify a mechanistic pathway relevant to neuroprotection and experimental autophagy research.

• Polybrene (Hexadimethrine Bromide): Optimizing Viral Gene De

  2026-05-02

  Polybrene (Hexadimethrine Bromide) amplifies viral gene transduction and DNA transfection efficiency, especially in challenging cell types. This guide offers a data-driven, protocol-centric roadmap for leveraging Polybrene’s unique properties, with actionable troubleshooting tips and cross-validated insights from recent mitochondrial metabolism research.

• GnRH Antagonists Modified with 3-(2-Methoxy-5-pyridyl)-alani

  2026-05-01

  This study introduces two novel degarelix analogs, each incorporating a diastereomeric form of 3-(2-methoxy-5-pyridyl)-alanine at position 3, to evaluate how stereochemistry affects GnRH receptor antagonism. The findings clarify structure-activity relationships critical for developing potent, long-acting peptide therapeutics targeting the reproductive axis.

• Tigecycline: Glycylcycline Antibiotic for MDR Infection Mode

  2026-04-30

  Tigecycline’s broad-spectrum and multidrug-resistant efficacy make it a cornerstone for modeling clinically relevant infections, including carbapenem-resistant Enterobacter cloacae and MRSA. This article delivers actionable protocols, troubleshooting strategies, and workflow enhancements to empower advanced antimicrobial research with APExBIO’s validated Tigecycline.

• Tunable Human Intestinal Organoids: Balancing Renewal and Di

  2026-04-30

  This study establishes a human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using small molecule pathway modulators. The platform enhances both proliferative capacity and cellular diversity within a single culture condition, improving scalability for high-throughput and disease modeling applications.

• Cefepime (BMY-28142): Powering CNS Infection Research & Resi

  2026-04-29

  This thought-leadership article dissects the mechanistic advantages and translational value of Cefepime (BMY-28142) for researchers tackling Gram-positive and Gram-negative infections—especially those affecting the central nervous system (CNS). Focusing on blood-brain barrier penetration, reproducibility in resistance models, and workflow-driven protocol guidance, the piece integrates new reference data and cross-links to in-depth workflow resources. Unlike standard product summaries, it deepens the discussion with strategic insights for translational teams, while grounding all numeric and workflow claims in peer-reviewed evidence or explicit recommendations.

• 3-Aminobenzamide (PARP-IN-1): Defining PARP Inhibition for I

  2026-04-29

  Explore how 3-Aminobenzamide (PARP-IN-1) advances poly (ADP-ribose) polymerase inhibition in immunometabolic and antiviral research. This article provides a rigorous, mechanism-focused analysis that extends beyond standard product guides, grounded in recent landmark studies.

• Tigecycline: Glycylcycline Antibiotic for Multidrug Resistan

  2026-04-28

  Tigecycline is a first-in-class glycylcycline antibiotic with potent activity against multidrug-resistant bacteria, including MRSA and CREC. Its mechanism involves 30S ribosomal subunit inhibition, contributing to efficacy in complicated skin and intra-abdominal infections, with high tissue penetration and minimal drug interaction risk.

• Cyclophilin A’s Essential Role in Cyclosporine Immunosuppres

  2026-04-28

  This study demonstrates that cyclophilin A is indispensable for cyclosporine-mediated immunosuppression in mice, as cyclophilin A-deficient animals exhibit resistance to the drug. These findings clarify the molecular specificity of calcineurin inhibition and have direct implications for experimental design in transplantation immunology and autoimmune disease research.

• Bestatin Hydrochloride (Ubenimex): Precision Aminopeptidase

  2026-04-27

  Bestatin hydrochloride (Ubenimex) is a dual inhibitor of aminopeptidase N and B, validated for angiogenesis inhibition and tumor research. Its precise mechanism and benchmarked protocols enable robust, reproducible results in cancer and neuropeptide studies.

• LG 101506: Applied RXR Modulator Workflows & Troubleshooting

  2026-04-27

  LG 101506 sets a new standard for RXR signaling pathway research, enabling reproducible and data-rich studies in immune checkpoint and metabolic regulation. This article delivers actionable protocols, advanced applications, and practical troubleshooting tips to maximize experimental success with this high-purity RXR modulator.

16398 records 1/1094 page Next 12345 下5页 Last page